Rachel Sanborn, M.D.

No bio available.

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Merck
    Topic: 
    Funding for investigator-sponsored trial
    Date added: 
    09/26/2022

Pages

Return to 2022 Seattle Multidisciplinary Thoracic Oncology Conference